Investor mix
10 investors on record; lead investors include Y Combinator, Caffeinated Capital; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 60% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 3 | 30% |
Provider of drug response predictions using living patient cells and biomarkers
10 investors on record; lead investors include Y Combinator, Caffeinated Capital; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 60% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 3 | 30% |